BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35240320)

  • 1. Efficient polymer nanoparticle-mediated delivery of gene editing reagents into human hematopoietic stem and progenitor cells.
    El-Kharrag R; Berckmueller KE; Madhu R; Cui M; Campoy G; Mack HM; Wolf CB; Perez AM; Humbert O; Kiem HP; Radtke S
    Mol Ther; 2022 Jun; 30(6):2186-2198. PubMed ID: 35240320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CCR5 Gene Edited CD34
    Karuppusamy KV; Demosthenes JP; Venkatesan V; Christopher AC; Babu P; Azhagiri MK; Jacob A; Ramalingam VV; Rangaraj S; Murugesan MK; Marepally SK; Varghese GM; Srivastava A; Kannangai R; Thangavel S
    Front Immunol; 2022; 13():792684. PubMed ID: 35359982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of Genome Editing Reagents to Hematopoietic Stem/Progenitor Cells.
    Hoban MD; Romero Z; Cost GJ; Mendel M; Holmes M; Kohn DB
    Curr Protoc Stem Cell Biol; 2016 Feb; 36():5B.4.1-5B.4.10. PubMed ID: 26840227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted, safe, and efficient gene delivery to human hematopoietic stem and progenitor cells in vivo using the engineered AVID adenovirus vector platform.
    Yao J; Atasheva S; Wagner N; Di Paolo NC; Stewart PL; Shayakhmetov DM
    Mol Ther; 2024 Jan; 32(1):103-123. PubMed ID: 37919899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic base editing of human hematopoietic stem cells.
    Zeng J; Wu Y; Ren C; Bonanno J; Shen AH; Shea D; Gehrke JM; Clement K; Luk K; Yao Q; Kim R; Wolfe SA; Manis JP; Pinello L; Joung JK; Bauer DE
    Nat Med; 2020 Apr; 26(4):535-541. PubMed ID: 32284612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Base Editing of Human Hematopoietic Stem Cells.
    Zeng J; Casirati G; Nguyen MA; Genovese P; Bauer DE
    Methods Mol Biol; 2023; 2606():43-62. PubMed ID: 36592307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential Expansion of Human CD34
    Christopher AC; Venkatesan V; Karuppusamy KV; Srinivasan S; Babu P; Azhagiri MKK; Chambayil K; Bagchi A; Rajendiran V; Ravi NS; Kumar S; Marepally SK; Mohankumar KM; Srivastava A; Velayudhan SR; Thangavel S
    Hum Gene Ther; 2022 Feb; 33(3-4):188-201. PubMed ID: 34486377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo hematopoietic stem cell modification by mRNA delivery.
    Breda L; Papp TE; Triebwasser MP; Yadegari A; Fedorky MT; Tanaka N; Abdulmalik O; Pavani G; Wang Y; Grupp SA; Chou ST; Ni H; Mui BL; Tam YK; Weissman D; Rivella S; Parhiz H
    Science; 2023 Jul; 381(6656):436-443. PubMed ID: 37499029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.
    Heinz N; Ehrnström B; Schambach A; Schwarzer A; Modlich U; Schiedlmeier B
    Stem Cells Transl Med; 2015 Sep; 4(9):1064-72. PubMed ID: 26160960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic gene editing in CD34
    Diez B; Genovese P; Roman-Rodriguez FJ; Alvarez L; Schiroli G; Ugalde L; Rodriguez-Perales S; Sevilla J; Diaz de Heredia C; Holmes MC; Lombardo A; Naldini L; Bueren JA; Rio P
    EMBO Mol Med; 2017 Nov; 9(11):1574-1588. PubMed ID: 28899930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA.
    Quintana-Bustamante O; Fañanas-Baquero S; Orman I; Torres R; Duchateau P; Poirot L; Gouble A; Bueren JA; Segovia JC
    PLoS One; 2019; 14(10):e0223775. PubMed ID: 31618280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in Hematopoietic Stem Cell Expansion and Gene Editing Technologies.
    Yucel D; Kocabas F
    Adv Exp Med Biol; 2018; 1079():103-125. PubMed ID: 29039064
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Shi D; Toyonaga S; Anderson DG
    Nano Lett; 2023 Apr; 23(7):2938-2944. PubMed ID: 36988645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells.
    Lee BC; Lozano RJ; Dunbar CE
    Mol Ther; 2021 Nov; 29(11):3205-3218. PubMed ID: 34509667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLGA-Nanoparticles for Intracellular Delivery of the CRISPR-Complex to Elevate Fetal Globin Expression in Erythroid Cells.
    Cruz LJ; van Dijk T; Vepris O; Li TMWY; Schomann T; Baldazzi F; Kurita R; Nakamura Y; Grosveld F; Philipsen S; Eich C
    Biomaterials; 2021 Jan; 268():120580. PubMed ID: 33321292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells.
    Yudovich D; Bäckström A; Schmiderer L; Žemaitis K; Subramaniam A; Larsson J
    Sci Rep; 2020 Dec; 10(1):22393. PubMed ID: 33372184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells.
    Radtke S; Kiem HP
    Methods Mol Biol; 2023; 2567():87-98. PubMed ID: 36255696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
    Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
    Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse models.
    Demirci S; Khan MBN; Hinojosa G; Le A; Leonard A; Essawi K; Gudmundsdottir B; Liu X; Zeng J; Inam Z; Chu R; Uchida N; Araki D; London E; Butt H; Maitland SA; Bauer DE; Wolfe SA; Larochelle A; Tisdale JF
    Cytotherapy; 2024 Feb; ():. PubMed ID: 38506770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution.
    Michallet M; Philip T; Philip I; Godinot H; Sebban C; Salles G; Thiebaut A; Biron P; Lopez F; Mazars P; Roubi N; Leemhuis T; Hanania E; Reading C; Fine G; Atkinson K; Juttner C; Coiffier B; Fière D; Archimbaud E
    Exp Hematol; 2000 Jul; 28(7):858-70. PubMed ID: 10907648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.